ARCHIVES

Addition of Immune Stimulant To Yervoy Therapy Increases Overall Survival, Study Says

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

Medicare Will Cover Patient Care Costs For All Phases Of Cancer Treatment Trials.

September 1, 2000

Oklahoma’s new cigarette tax will provide $7 million a year to the University of Oklahoma Cancer Center.

November 5, 2004

Study Finds Up To 12 Percent Of Specimens Misdiagnosed

October 28, 2005

RFAs Available: Silicone And Immune Response; Role Of Metallotionein; Dietary Fat Biomarkers

September 11, 1992

Freeman Reappointed President’s Cancer Panel Chairman

September 16, 1994

In Brief: Radiation Therapy Pioneer Juan Del Regato Dead At 90

July 16, 1999